GCA
TNDM icon

Gideon Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Gideon Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,134
Closed -$771K – 428
2019
Q1 		$771K Buy
+12,134
New +$637K 0.28% 94

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Gideon Capital Advisors's TNDM Position: Q2 2019 in Review

Gideon Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2019, closing a stake of 12,134 shares — an estimated $771K sold.

Gideon Capital Advisors first reported a position in TNDM in Q1 2019 and held it in 1 quarter. The position peaked at $771K in Q1 2019. 261 funds tracked by Wall St. Rank hold TNDM as of Q2 2019.

  • Gideon Capital Advisors reported no remaining Tandem Diabetes Care position as of Q2 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 12,134 Tandem Diabetes Care shares in Q2 2019, an estimated $771K.
  • Gideon Capital Advisors first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 1 quarter.
  • Gideon Capital Advisors's Tandem Diabetes Care position peaked at $771K in Q1 2019.
  • 261 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2019.

Based on Gideon Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.